HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

Epilepsia. 2010 Dec;51(12):2461-5. doi: 10.1111/j.1528-1167.2010.02766.x. Epub 2010 Nov 3.

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening severe cutaneous adverse reactions. Recently, strong associations of HLA-B*1502 with carbamazepine-induced SJS/TEN have been found in Han Chinese patients. These associations have been confirmed in several Asian populations, excluding Japanese. SJS patients carrying HLA-B*1508, HLA-B*1511, or HLA-B*1521, which are members of the HLA-B75 type along with HLA-B*1502, were detected in studies in India and Thailand. In the current study, we genotyped the HLA-B locus from 14 Japanese typical and atypical SJS/TEN patients in whom carbamazepine was considered to be involved in the onset of adverse reactions. Although there were no HLA-B*1502 carriers, four patients had HLA-B*1511. Our data suggest that HLA-B*1511, a member of HLA-B75, is a risk factor for carbamazepine-induced SJS/TEN in Japanese.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Asian People / genetics*
  • Carbamazepine / adverse effects*
  • Carbamazepine / therapeutic use
  • Child
  • Family
  • Female
  • Genotype
  • HLA-B Antigens / genetics*
  • HLA-B15 Antigen
  • Humans
  • Indien
  • Male
  • Middle Aged
  • Pharmacogenetics
  • Risk Factors
  • Stevens-Johnson Syndrome / genetics*
  • Thailand

Substances

  • HLA-B Antigens
  • HLA-B*15:02 antigen
  • HLA-B15 Antigen
  • Carbamazepine